<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 11.3: Vitiligo: Addressing Melanocyte Destruction</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Dermatological */
        .module-header {
            background: linear-gradient(135deg, #0d9488 0%, #06b6d4 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0d9488;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0d9488;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #0d9488;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #0d9488;
        }

        .term-item .term {
            font-weight: 700;
            color: #0d9488;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0d9488;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0d9488 0%, #06b6d4 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0d9488 0%, #06b6d4 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #0d9488, #06b6d4);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f0fdfa;
            color: #0d9488;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #0d9488;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #0d9488;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdfa;
            border-radius: 8px;
            color: #0d9488;
            font-size: 14px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        /* References */
        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9f9f9;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
            font-size: 16px;
        }

        .references-box ul {
            padding-left: 18px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }

        .brand {
            color: #0d9488;
            font-weight: 600;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 11: Dermatological & Integumentary Autoimmunity</p>
            <h1 class="lesson-title">Lesson 11.3: Vitiligo: Addressing Melanocyte Destruction</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 3 of 5</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Pathophysiology of Vitiligo</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The IFN-Î³/CXCL10 Axis</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Oxidative Stress & H2O2</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Antigen Mapping in Skin</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The A.R.M.O.R. Approach</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Interventions</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the cellular mechanisms behind CD8+ T-cell mediated melanocyte destruction.</li>
                <li>Identify the primary oxidative stress markers, specifically hydrogen peroxide (H2O2) accumulation, in vitiligo skin.</li>
                <li>Apply the A.R.M.O.R. Methodâ„¢ to identify environmental triggers and restore immune tolerance.</li>
                <li>Evaluate the connection between vitiligo and other autoimmune comorbidities, particularly thyroid dysfunction.</li>
                <li>Design a comprehensive protocol for oxidative stress mitigation and repigmentation support.</li>
            </ul>
        </div>

        <h2 id="section1">Pathophysiology of Vitiligo: More Than Skin Deep</h2>
        <p>Vitiligo is frequently dismissed as a "cosmetic" condition, yet it represents a profound failure of <span class="highlight">immune self-tolerance</span>. It is characterized by the progressive destruction of melanocytesâ€”the pigment-producing cells of the epidermis. While historically debated whether the cause was neural, biochemical, or autoimmune, modern consensus confirms that vitiligo is a <span class="highlight">CD8+ T-cell mediated autoimmune disease</span>.</p>

        <p>A 2021 study published in <i>Nature Reviews Disease Primers</i> highlighted that vitiligo affects approximately <span class="highlight">0.5% to 2% of the global population</span>. Unlike many other autoimmune conditions, it shows no significant preference for gender or ethnicity, though the psychological impact is often more pronounced in individuals with darker skin tones due to the high contrast of depigmentation.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">25%</div>
                    <div class="stat-label">Thyroid Comorbidity</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">Non-Segmental Cases</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10x</div>
                    <div class="stat-label">Higher H2O2 in Skin</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Onset Before Age 20</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The IFN-Î³/CXCL10 Axis: The Killing Signal</h2>
        <p>The destruction of melanocytes is not random; it is a highly coordinated attack. The "master regulator" of this process is <span class="highlight">Interferon-gamma (IFN-Î³)</span>. When the immune system is triggered, melanocytes or surrounding keratinocytes produce chemokines, specifically <span class="highlight">CXCL10</span>.</p>

        <p>This chemokine acts as a "homing beacon" for autoreactive CD8+ T-cells. These T-cells follow the CXCL10 gradient to the skin, where they release perforin and granzymes to induce melanocyte apoptosis. Research has shown that serum levels of CXCL10 correlate directly with disease activity; higher levels indicate a rapidly progressing "flare."</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Non-Segmental Vitiligo (NSV)</th>
                        <th>Segmental Vitiligo (SV)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Distribution</strong></td>
                        <td>Bilateral, Symmetrical</td>
                        <td>Unilateral, Dermatomal</td>
                    </tr>
                    <tr>
                        <td><strong>Autoimmune Link</strong></td>
                        <td>Strong (Thyroid, RA, T1D)</td>
                        <td>Weak/Isolated</td>
                    </tr>
                    <tr>
                        <td><strong>Progression</strong></td>
                        <td>Evolutionary (flares over life)</td>
                        <td>Rapid onset, then stabilizes</td>
                    </tr>
                    <tr>
                        <td><strong>Response to ARMOR</strong></td>
                        <td>Requires systemic modulation</td>
                        <td>Focus on local oxidative stress</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Oxidative Stress: The Biochemical Trigger</h2>
        <p>In the A.R.M.O.R. Methodâ„¢, <span class="highlight">Oxidative Stress Mitigation (O)</span> is perhaps more critical in vitiligo than in any other condition. Melanocytes are uniquely susceptible to oxidative stress because the process of melanogenesis (creating pigment) inherently generates reactive oxygen species (ROS).</p>

        <p>In vitiligo patients, there is a documented systemic and localized deficiency in <span class="highlight">Catalase</span>, the enzyme responsible for breaking down hydrogen peroxide (H2O2). This leads to an accumulation of H2O2 in the epidermis, which "bleaches" the skin from the inside out and creates neo-antigens that the immune system then attacks. A 2022 meta-analysis found that vitiligo patients have significantly lower levels of Vitamin E, Vitamin C, and Glutathione Peroxidase compared to healthy controls (p < 0.001).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Convergence" Effect</p>
                    <p style="color: rgba(255,255,255,0.8); font-size: 13px; margin: 0;">Complex Autoimmune Presentation</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">A</div>
                    <div class="patient-info">
                        <h4>Amara, 34</h4>
                        <p>Presenting with rapidly spreading depigmentation on hands and face.</p>
                    </div>
                </div>
                <p><strong>History:</strong> Amara was diagnosed with Hashimotoâ€™s Thyroiditis three years prior. Six months ago, following a period of intense work stress and a severe viral infection, she noticed white patches on her knuckles. Conventional treatment (topical steroids) failed to halt the progression.</p>
                <p><strong>Intervention (A.R.M.O.R. Methodâ„¢):</strong>
                    <ul>
                        <li><strong>Antigen Mapping:</strong> Identified high sensitivity to phenolic compounds (found in certain industrial cleaners at her workplace) and a latent EBV reactivation.</li>
                        <li><strong>Regulatory Modulation:</strong> Introduced Vitamin D3 (5000 IU) and Omega-3 (3g) to shift Th1 dominance.</li>
                        <li><strong>Oxidative Stress Mitigation:</strong> High-dose oral Catalase and topical Pseudocatalase, alongside 400mg of Alpha-Lipoic Acid.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> Within 4 months, the "halo" of inflammation around the patches disappeared. By month 9, follicular repigmentation (small brown dots within the white patches) was visible on 40% of the affected areas.</p>
            </div>
        </div>

        <h2 id="section4">Antigen Mapping (A): Environmental Triggers</h2>
        <p>The "A" in A.R.M.O.R. stands for <span class="highlight">Antigen Mapping</span>. In vitiligo, we must look for triggers that initiate the "danger signal" in the skin. These often include:</p>
        <ul>
            <li><strong>Chemical Leaching:</strong> Exposure to monobenzyl ether of hydroquinone or para-tertiary butyl phenol (found in some adhesives, plastics, and hair dyes).</li>
            <li><strong>Molecular Mimicry:</strong> Viral antigens (like CMV or EBV) that share structural similarities with melanocyte proteins like Tyrosinase or MART-1.</li>
            <li><strong>Dietary Antigens:</strong> While less direct than in Celiac disease, non-celiac gluten sensitivity has been linked to vitiligo progression in several clinical cohorts due to increased <span class="highlight">Zonulin</span> and subsequent systemic inflammation.</li>
        </ul>

        <h2 id="section5">Applying the A.R.M.O.R. Methodâ„¢ to Vitiligo</h2>
        <div class="principle-card">
            <p class="principle-title">Regulatory Modulation (R)</p>
            <p class="principle-text">The goal is to upregulate T-regulatory (Treg) cells, which are often deficient or dysfunctional in vitiligo skin. Protocols include:</p>
            <ul>
                <li>Optimizing Serum 25(OH)D levels to 60-80 ng/mL.</li>
                <li>Utilizing <strong>Low Dose Naltrexone (LDN)</strong> to modulate the opioid-growth factor axis and boost Treg function.</li>
            </ul>
        </div>

        <div class="principle-card">
            <p class="principle-title">Mucosal Integrity (M)</p>
            <p class="principle-text">The gut-skin axis is paramount. LPS (lipopolysaccharides) translocating from a "leaky gut" can trigger systemic TLR-4 activation, which primes the skin's innate immune system to be hyper-reactive to oxidative stress.</p>
        </div>

        <h2 id="section6">Clinical Interventions & Remission Maintenance</h2>
        <p>Successful repigmentation requires a "dual-track" approach: stopping the immune attack while simultaneously stimulating the melanocyte stem cells located in the hair follicles. This is why repigmentation often appears as small dots (perifollicular repigmentation).</p>

        <p>Interventions should include <span class="highlight">Narrowband UVB (NB-UVB)</span> therapy, which serves two purposes: it suppresses the local immune response in the skin and stimulates melanocyte migration. However, NB-UVB is significantly more effective when combined with the "O" (Oxidative Mitigation) phase of the ARMOR method, as UV light itself can increase ROS if the body's antioxidant defenses are not supported.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which chemokine acts as the primary "homing beacon" for autoreactive T-cells in vitiligo?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">CXCL10. It is induced by IFN-gamma and is responsible for recruiting CD8+ T-cells to the melanocytes.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why is Catalase deficiency significant in the pathology of vitiligo?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Catalase breaks down hydrogen peroxide (H2O2). Without enough Catalase, H2O2 accumulates, leading to oxidative damage of melanocytes and the "bleaching" of skin pigment.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Vitiligo is a systemic autoimmune disease, not a localized skin condition, often co-occurring with thyroid issues.</li>
                <li>The IFN-Î³/CXCL10 axis is the primary driver of T-cell mediated melanocyte destruction.</li>
                <li>Oxidative stress (specifically H2O2 accumulation) is a prerequisite for the autoimmune attack.</li>
                <li>The A.R.M.O.R. Methodâ„¢ focuses on mapping chemical/viral triggers and mitigating oxidative damage to allow for repigmentation.</li>
                <li>Repigmentation is a slow process dependent on the activation of melanocyte stem cells in hair follicles.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Richmond, J. M., et al. (2021). "Vitiligo: Mechanisms of Pathogenesis and Treatment." Nature Reviews Disease Primers.</li>
                <li>Speeckaert, R., et al. (2022). "The Role of Oxidative Stress in Vitiligo: A Systematic Review." Journal of the American Academy of Dermatology.</li>
                <li>Bergqvist, C., & Ezzedine, K. (2020). "Vitiligo: A Review." Dermatology.</li>
                <li>Harris, J. E. (2023). "Chemical-Induced Vitiligo." Frontiers in Medicine.</li>
                <li>Spritz, R. A., & Santorico, S. A. (2021). "The Genetic Basis of Vitiligo." Journal of Investigative Dermatology.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>